Creative Bioarray Develops More Than 1000 Cell Types Together with Selective Cell Culture Media

Creative Bioarray announced the release of its comprehensive primary cell types together with selective cell culture media to accelerate life science research.

USA - November 2, 2022 /MarketersMEDIA/ —

Creative Bioarray, as a global biotechnology company, supporting and collaborating with scientists around the world to achieve their research goals, is dedicated to providing high-quality cell culture media, cell separation technologies, and instruments to scientists around the world working on cell culture, immunology, cancer, regenerative medicine, and cellular therapy research. Recently, Creative Bioarray announced the release of its comprehensive primary cell types together with selective cell culture media to accelerate life science research.

Human primary cells are commonly used in vitro for preclinical and research biological studies, such as inter- and intracellular communication, developmental biology, and mechanistic studies in cancer, Parkinson's disease, and diabetes. Human primary cells derived from a specific tissue and maintained with appropriate primary cell culture media and supplements now represent a more advanced model than immortalized cells to recapitulate that tissue cell type.

Creative Bioarray's team of cell culture experts provides you with a unique collection of high-purity, low-passage human and animal primary cells. Our primary cells cover a wide variety of cell types (epithelial, endothelial, smooth muscle and many other key types) from a variety of tissues (skin, liver, bone, brain, etc.), including cryopreserved and proliferative state formats.

Creative Bioarray also manufactures a variety of cell culture media. Each medium is balanced and supplemented for specific cell types to maximize the life expectancy of individual cell types. Creative Bioarray offers over 1000 cell types and selective cell culture media for a variety of tissues. The team is currently developing multiple cell types, in addition, the cells of the Creative Bioarray are valuable innovative cell factories for the production of recombinant complex molecules or extracellular vesicles.

Animal primary cells from the Creative Bioarray are isolated from normal or diseased animal tissue. They are rigorously quality tested for studies of basic cell biology, cell cycle mechanisms, specialized cell functions, cell-cell and cell-matrix interactions.

Creative Bioarray also provides ready-to-use liquid formulations, as well as custom options for powder media and formula modifications. Creative Bioarray is committed to providing fully tested, high-quality products that do not adversely affect cells during the isolation process. SuperBeads® Magnetic Separation Technology can be used to isolate pure, viable and functional cells of the immune system to advance immunology research.

“We can provide a wide range of cell-based drug discovery assays throughout the drug development process,” said Hannah Cole, the marketing director of Creative Bioarray, she also claimed, “With our in-depth scientific and technical expertise, Creative Bioarray will be your best partner in the drug development field. And we are capable to provide customized solutions to satisfy your specific needs.”

About Creative Bioarray

Creative Bioarray is dedicated to offering customers innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house expert support, Creative Bioarray has already countenanced research all around the world.

Contact Info:
Name: Hannah Cole
Email: Send Email
Organization: Creative Bioarray
Address: Shirley, NY 11967, USA
Phone: 1 631 386 8241
Website: https://www.creative-bioarray.com/

Release ID: 89084156

If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 8 hours.